This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
A lack of up-to-date New Zealand research into common gut disorders means the country is effectively flying blind on conditions that may affect about 1 in 3 adults, University of Otago research suggests.
Dr. Simone Bayer and research colleagues from the University of Otago have reviewed all available evidence in Aotearoa on disorders of gut-brain interaction (DGBI)—a group of chronic conditions including irritable bowel syndrome (IBS) and functional dyspepsia. Their findings, published in the New Zealand Medical Journal, reveal a striking lack of contemporary data on how common these conditions are, who is affected and what costs they incur to our health system.
Only four New Zealand studies reporting the prevalence of DGBI were identified, with the most recent published in 2002. The studies were limited to Wellington and Dunedin, and none provided prevalence data for Māori or Pacific peoples.
"People living with these conditions can experience significant and ongoing symptoms, yet we don't have any strong contemporary evidence telling us how many New Zealanders are affected," Bayer says. "That means we are also unable to properly comprehend the scale of demand on our health system, or whether different groups of New Zealanders are experiencing these conditions and accessing care in different ways."
DGBI, formerly known as functional gastrointestinal disorders, affect the way the gut functions without an identifiable structural or organic disease being found.
Source link







